BROAD MOLECULAR PROFILING FOR SOLID TUMORS

xT Solid Tumor + Normal Match DNA Sequencing xR RNA Whole Transcriptome Sequencing

Solid tumor + normal matched testing is DNA sequencing of a solid tumor biopsy and a normal sample (blood or saliva) simultaneously.

Through our tumor/normal match approach, there is a 28% reduction in somatic false-positive calls and improving variant accuracy compared to a tumor-only analysis. Tumor/normal match sequencing may additionally detect incidental germline findings in a limited set of genes, for which a validated germline panel may be indicated for confirmatory testing.
 

Specimen Requirements

FFPE solid tumor tissue
Tumor required to be at least 20% of the sample by ratio of tumor nuclei to benign nuclei